Nuclear matrix protein 22

Known as: NMP22 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Cystoscopy and voided urine cytology as gold standards for the detection of bladder cancer (BCa) have limitations because… (More)
  • table 1
  • table 1
Is this relevant?
2011
2011
BACKGROUND Several studies have demonstrated that abnormal levels of nuclear matrix protein 22 (NMP22) are associated with… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2011
2011
OBJECTIVE To investigate the diagnostic value of the nuclear matrix protein 22 (NMP22) test in comparison to urine cytology for… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
OBJECTIVES To assess the efficacy of nuclear matrix protein 22 (NMP-22) in the diagnosis of recurrent, superficial bladder cancer… (More)
  • table 1
  • table 2
  • table 3
  • table 1
Is this relevant?
2008
2008
INTRODUCTION The aim of this study was to determine the diagnostic value of urine nuclear matrix protein 22 (NMP22) level in… (More)
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE We developed and validated nomograms that accurately predict disease recurrence and progression in patients with Ta, T1… (More)
Is this relevant?
2005
2005
OBJECTIVE To determine the incidence of positive urinary nuclear matrix protein 22 (NMP22) values, which are currently used to… (More)
Is this relevant?
1999
1999
PURPOSE The aim of the present study was to determine the clinical usefulness of nuclear matrix protein 22 (NMP22) as a new… (More)
Is this relevant?
1998
1998
BACKGROUND Nuclear matrix protein 22 (NMP22) is a parameter of cell death including apoptosis. To evaluate the clinical efficacy… (More)
Is this relevant?
1997
1997
OBJECTIVES This study was undertaken to determine the clinical usefulness of nuclear matrix protein 22 (NMP22) as a novel urine… (More)
Is this relevant?